HCP ELISA Leadership BioGenes’ core strengths include customized antibody development and robust ELISA and HCP assays, enabling cross-sell opportunities to pharmaceutical and biotech customers who require reliable QC analytics across discovery, development, and manufacturing.

Global Partnerships With long standing relationships spanning global pharma, biotech, CMOs and IVD firms across multiple countries, there is potential to deepen engagements through expanded service lines, bundled offerings, and co development collaborations with existing customers.

Joint Development Opportunities Recent collaboration with Gyros Protein Technologies to develop ready-to-use HEK293 HCP kit reagents demonstrates a scalable, repeatable product path that can be expanded to other cell lines and assays, creating a channel for kit-based upsell alongside customized services.

Integrated Diagnostics QC Full-spectrum capabilities from antibody discovery to quality control for biological products and diagnostic applications position BioGenes to offer integrated testing workflows, appealing to customers seeking one-stop partner for both development and analytical services.

Regional Market Expansion Strategic regional partnerships such as Sensor Malaysia provide a template for market entry in new regions, supported by local collaboration and knowledge transfer to accelerate adoption of BioGenes’ ELISA kits and analytical services.